Full Text View
Tabular View
No Study Results Posted
Related Studies
Bioequivalence and Food Effect of 250mg of Lamotrigine XR
This study has been completed.
Study NCT00605371   Information provided by GlaxoSmithKline
First Received: January 18, 2008   Last Updated: October 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
Bipolar Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Brain Diseases
Central Nervous System Diseases
Mental Disorders
Mood Disorders
Nervous System Diseases
Interventions listed in this trial
Lamotrigine
More general drug interventions related to this trial
Anticonvulsants
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services